Suppr超能文献

展望糖尿病管理改善的未来:采访史蒂夫·贝恩教授

Looking to a future of improved diabetes management: interview with Professor Steve Bain.

作者信息

Bain Steve

机构信息

Institute of Life Science, Swansea University & Clinical Director, Diabetes Research Unit Cymru, Swansea, Wales, SA2 8PP.

出版信息

Future Sci OA. 2016 Oct 27;2(4):FSO154. doi: 10.4155/fsoa-2016-0069. eCollection 2016 Dec.

Abstract

Steve is currently a Professor at Swansea University Medical School (Wales), Assistant Medical Director for Research & Development for ABM University Health Board and Clinical Lead for the Diabetes Research Unit, Wales. His clinical training included research into the genetics of Type 1 diabetes, with his current clinical interests surrounding exercise in Type 1 diabetes, new therapies and the provision of diabetes services. His background has led him to be Principal Investigator for several multicenter trials, and to be involved in various ethical committees concerning genetics. He led the UK Human Genetics Commission's report on DNA testing in 2009, and in 2007 was invited to sit on the National DNA Database Ethics Group, established by the Secretary of State for the Home Department. Steve is also a member of the Wales Diabetes & Endocrine Society executive committee and chairs the Specialist Training Committee for Diabetes & Endocrinology for Wales. He also chairs the Board that oversees the Institute of Life Science Joint Clinical Research Facility, the premier clinical research institute in Wales.

摘要

史蒂夫目前是斯旺西大学医学院(威尔士)的教授,阿伯多维大学健康委员会研发部助理医学主任以及威尔士糖尿病研究单位临床负责人。他的临床培训包括对1型糖尿病遗传学的研究,他目前的临床兴趣围绕1型糖尿病中的运动、新疗法以及糖尿病服务的提供。他的背景使他成为多个多中心试验的首席研究员,并参与了多个有关遗传学的伦理委员会。他在2009年领导了英国人类遗传学委员会关于DNA检测的报告,并于2007年受邀加入由内政大臣设立的国家DNA数据库伦理小组。史蒂夫还是威尔士糖尿病与内分泌学会执行委员会成员,并担任威尔士糖尿病与内分泌学专科培训委员会主席。他还担任监督威尔士首屈一指的临床研究机构生命科学研究所联合临床研究设施的董事会主席。

相似文献

4
Advances in immunotherapy for melanoma.黑色素瘤免疫疗法的进展
Melanoma Manag. 2014 Aug;1(1):19-24. doi: 10.2217/mmt.14.4. Epub 2014 Sep 5.
5
Obesity, gut hormones and knighthood.肥胖、肠道激素与骑士勋章。
Expert Rev Endocrinol Metab. 2013 May;8(3):225-227. doi: 10.1586/eem.13.17.

本文引用的文献

1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.司美格鲁肽与 2 型糖尿病患者的心血管结局
N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验